MK-8931 (MRK, LGND) There has not yet been anything to indicate they have formally advanced into phase 3. Update: MRK started enrolling in the Phase-3 Prodromal study. http://clinicaltrials.gov/ct2/show/NCT01953601?term=MK-8931&rank=3